LITS Lite Strategy Inc.
- Stocks
- Healthcare
- NASDAQ: LITS
Price (delayed)
$1.85
Market cap
$65.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.39
Enterprise value
$47.95M
Relative Growth:
Rel. Growth:
3
Relative Strength:
Rel. Strength:
4
Relative Valuation:
Rel. Valuation:
N/A
Relative Profitability:
Rel. Profitability:
0
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta
Highlights
The EPS has plunged by 190% YoY but it has grown by 50% from the previous quarter
LITS's net income has dropped by 190% year-on-year but it is up by 50% since the previous quarter
Lite Strategy's gross profit has shrunk by 100% YoY
LITS's revenue has shrunk by 100% YoY
Key stats
What are the main financial stats of LITS
Market
Valuations
Earnings
Shares outstanding
35.66M
Market cap
$65.96M
Enterprise value
$47.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.73
Price to sales (P/S)
N/A
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$17.46M
Net income
-$15.95M
EBIT
-$15.95M
EBITDA
-$15.36M
Free cash flow
-$20.83M
Per share
Balance sheet
Liquidity
EPS
-$2.39
EPS diluted
-$2.39
Free cash flow per share
-$3.13
Book value per share
$2.54
Revenue per share
$0
TBVPS
$2.74
Total assets
$18.29M
Total liabilities
$1.35M
Debt
$0
Equity
$16.93M
Working capital
$16.93M
Debt to equity
0
Current ratio
13.5
Quick ratio
13.3
Net debt/EBITDA
1.17
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-69.9%
Return on equity
-76.4%
Return on invested capital
-446.8%
Return on capital employed
-94.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LITS stock price
How has the Lite Strategy stock price performed over time
Intraday
5.11%
1 week
-11.06%
1 month
-27.73%
1 year
-39.14%
YTD
-24.8%
QTD
-23.55%
Financial performance
How have Lite Strategy's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$17.46M
Net income
-$15.95M
Gross margin
N/A
Net margin
N/A
LITS's net income has dropped by 190% year-on-year but it is up by 50% since the previous quarter
Lite Strategy's gross profit has shrunk by 100% YoY
LITS's revenue has shrunk by 100% YoY
The operating income has grown by 48% from the previous quarter
Price vs fundamentals
How does LITS's price correlate with its fundamentals
Growth
What is Lite Strategy's growth rate over time
Valuation
What is Lite Strategy stock price valuation
P/E
N/A
P/B
0.73
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 190% YoY but it has grown by 50% from the previous quarter
The stock's price to book (P/B) is 70% less than its 5-year quarterly average of 2.4 and 9% less than its last 4 quarters average of 0.8
The equity fell by 49% YoY and by 13% QoQ
LITS's revenue has shrunk by 100% YoY
Efficiency
How efficient is Lite Strategy business performance
Lite Strategy's ROIC has plunged by 58% from the previous quarter
The ROE rose by 40% QoQ
LITS's return on assets is up by 37% since the previous quarter
Dividends
What is LITS's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Lite Strategy financials performed over time
The company's quick ratio has surged by 190% YoY but it fell by 20% QoQ
Lite Strategy's current ratio has surged by 177% YoY but it has decreased by 20% QoQ
Lite Strategy's debt is 100% lower than its equity
The equity fell by 49% YoY and by 13% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.